These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37624932)

  • 1. Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid.
    Afflerbach AK; Rohrandt C; Brändl B; Sönksen M; Hench J; Frank S; Börnigen D; Alawi M; Mynarek M; Winkler B; Ricklefs F; Synowitz M; Dührsen L; Rutkowski S; Wefers AK; Müller FJ; Schoof M; Schüller U
    Clin Chem; 2024 Jan; 70(1):250-260. PubMed ID: 37624932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.
    Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P
    Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.
    Ronsley R; Karvonen KA; Cole B; Paulson V; Stevens J; Crotty EE; Hauptman J; Lee A; Stasi SM; Lockwood CM; Leary SES
    J Neurooncol; 2024 Jun; 168(2):215-224. PubMed ID: 38755519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid.
    Cornelli L; Van Paemel R; Ferro Dos Santos MR; Roelandt S; Willems L; Vandersteene J; Baert E; Mus LM; Van Roy N; De Wilde B; De Preter K
    Clin Epigenetics; 2024 Jul; 16(1):87. PubMed ID: 38970137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
    Li M; Chen J; Zhang B; Yu J; Wang N; Li D; Shao Y; Zhu D; Liang C; Ma Y; Ou Q; Hou X; Chen L
    BMC Med; 2022 Nov; 20(1):398. PubMed ID: 36372873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System Glioma.
    Iser F; Hinz F; Hoffmann DC; Grassl N; Güngoör C; Meyer J; Dörner L; Hofmann L; Kelbch V; Göbel K; Mahmutoglu MA; Vollmuth P; Patel A; Nguyen D; Kaulen LD; Mildenberger I; Sahm K; Maaß K; Pajtler KW; Shankar GM; Weiler M; Wildemann B; Winkler F; von Deimling A; Platten M; Wick W; Sahm F; Kessler T
    Clin Cancer Res; 2024 Jul; 30(14):2974-2985. PubMed ID: 38295147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients.
    Martignano F; Munagala U; Crucitta S; Mingrino A; Semeraro R; Del Re M; Petrini I; Magi A; Conticello SG
    Mol Cancer; 2021 Feb; 20(1):32. PubMed ID: 33579306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients.
    Miller AM; Szalontay L; Bouvier N; Hill K; Ahmad H; Rafailov J; Lee AJ; Rodriguez-Sanchez MI; Yildirim O; Patel A; Bale TA; Benhamida JK; Benayed R; Arcila ME; Donzelli M; Dunkel IJ; Gilheeney SW; Khakoo Y; Kramer K; Sait SF; Greenfield JP; Souweidane MM; Haque S; Mauguen A; Berger MF; Mellinghoff IK; Karajannis MA
    Neuro Oncol; 2022 Oct; 24(10):1763-1772. PubMed ID: 35148412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanopore sequencing reveals methylation changes associated with obesity in circulating cell-free DNA from Göttingen Minipigs.
    Drag MH; Debes KP; Franck CS; Flethøj M; Lyhne MK; Møller JE; Ludvigsen TP; Jespersen T; Olsen LH; Kilpeläinen TO
    Epigenetics; 2023 Dec; 18(1):2199374. PubMed ID: 37032646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
    Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N
    Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients.
    Guo W; Jin L; Liang J; Lin G; Zheng J; Zhou D; Zhan S; Sun H; Jiang X
    Clin Chim Acta; 2022 Sep; 534():81-92. PubMed ID: 35810802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up.
    Boons G; Vandamme T; Mariën L; Lybaert W; Roeyen G; Rondou T; Papadimitriou K; Janssens K; Op de Beeck B; Simoens M; Demey W; Dero I; Van Camp G; Peeters M; Op de Beeck K
    Clin Cancer Res; 2022 Jan; 28(2):338-349. PubMed ID: 34759042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing.
    Sun X; Liu X; Zhao Y; Tian G; Wang W
    Methods Mol Biol; 2023; 2695():27-46. PubMed ID: 37450110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
    Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
    van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
    EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing.
    Lau BT; Almeda A; Schauer M; McNamara M; Bai X; Meng Q; Partha M; Grimes SM; Lee H; Heestand GM; Ji HP
    Genome Med; 2023 May; 15(1):33. PubMed ID: 37138315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma.
    Connolly ID; Li Y; Pan W; Johnson E; You L; Vogel H; Ratliff J; Hayden Gephart M
    J Neurooncol; 2017 Oct; 135(1):29-36. PubMed ID: 28900844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas.
    Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D
    BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.